mdr-745-specialist

1. MDR Classification and Risk Assessment

Provide expert guidance on device classification under MDR Annex VIII and conformity assessment route selection.

Classification Decision Framework:

1. Preliminary Classification Assessment

- Apply MDR Annex VIII classification rules

- Consider device duration, invasiveness, and body system interaction

- Evaluate software classification per MDCG 2019-11

- Decision Point: Determine appropriate classification class (I, IIa, IIb, III)

1. Classification Justification

- Document classification rationale per references/mdr-classification-guide.md

- Consider borderline cases and MDCG guidance

- Evaluate combination device implications

- Validate classification with Notified Body consultation

1. Conformity Assessment Route Selection

- Class I: Self-certification under Annex II

- Class IIa: Module C2 + Annex V (Notified Body involvement)

- Class IIb: Module B + C or D (Type examination + production)

- Class III: Module B + C or D (Full quality assurance)

2. Technical Documentation Requirements (Annex II & III)

Ensure comprehensive technical file preparation meeting all MDR documentation requirements.

Technical Documentation Structure:

```

ANNEX II TECHNICAL DOCUMENTATION

├── General Information

│ ├── Device identification and UDI-DI

│ ├── Manufacturer and authorized representative info

│ ├── Intended purpose and clinical condition

│ └── Device description and variants

├── Information to be Supplied by Manufacturer

│ ├── Label and instructions for use

│ ├── Clinical evaluation and post-market clinical follow-up

│ ├── Risk management documentation

│ └── Product verification and validation

├── Design and Manufacturing Information

│ ├── Quality management system documentation

│ ├── Design and development process

│ ├── Manufacturing process description

│ └── Identification and traceability procedures

└── General Safety and Performance Requirements

├── Solutions adopted for GSPR compliance

├── Benefit-risk analysis and risk management

├── Product lifecycle and post-market surveillance

└── Clinical evidence and evaluation

```

3. Clinical Evidence Requirements (Annex XIV)

Manage comprehensive clinical evidence strategies ensuring MDR compliance and scientific rigor.

Clinical Evidence Pathway Selection:

1. Literature-Based Evidence

- Systematic literature review methodology

- Appraisal of clinical data per MEDDEV 2.7/1 rev.4

- Gap analysis and additional evidence requirements

- Decision Point: Determine if literature is sufficient or clinical investigation required

1. Clinical Investigation Requirements

- For significant changes or novel devices

- For Class III implantable devices (Article 61)

- Clinical investigation plan development

- Ethics committee and competent authority approvals

1. Post-Market Clinical Follow-up (PMCF)

- PMCF Plan development per Annex XIV Part B

- PMCF Evaluation Report (PMCF-ER) preparation

- Clinical evaluation report updating requirements

- Integration with post-market surveillance system

4. UDI System Implementation (Article 27)

Implement comprehensive Unique Device Identification system meeting MDR requirements and EUDAMED integration.

UDI Implementation Workflow:

1. UDI Strategy Development

- UDI-DI assignment for device variants

- UDI-PI requirements for higher risk devices

- EUDAMED registration timeline planning

- Labeling compliance verification

1. EUDAMED Registration

- Actor registration (manufacturers, authorized representatives)

- Device registration and UDI-DI assignment

- Certificate registration (Notified Body certificates)

- Clinical investigation and serious incident reporting

Gap Analysis and Transition Planning

Conduct systematic gap assessments against current MDR requirements and develop comprehensive transition strategies.

Gap Analysis Framework:

1. Current State Assessment

- Existing QMS compliance evaluation

- Technical documentation gap identification

- Clinical evidence adequacy assessment

- Post-market surveillance system review

1. MDR Requirement Mapping

- For existing devices: Legacy directive vs. MDR requirements

- For new devices: Full MDR compliance roadmap

- For software: Software-specific MDR requirements per MDCG guidance

- Resource and timeline impact assessment

Post-Market Surveillance (Chapter VII)

Establish robust post-market surveillance systems meeting MDR requirements for continuous safety monitoring.

PMS System Components:

• PMS Plan development per Article 84
• Periodic Safety Update Report (PSUR) preparation
• Serious incident reporting to competent authorities
• Field safety corrective actions (FSCA) management
• Trend reporting and signal detection

Economic Operator Obligations

Ensure compliance with expanded economic operator responsibilities under MDR.

Key Obligations Management:

• Manufacturer obligations (Article 10)
• Authorized representative duties (Article 11)
• Importer responsibilities (Article 13)
• Distributor obligations (Article 14)
• Person responsible for regulatory compliance (Article 15)

Notified Body Selection and Management

Provide strategic guidance on Notified Body selection and relationship management throughout the conformity assessment process.

Notified Body Engagement Strategy:

1. Selection Criteria Assessment

- Technical competency evaluation

- Capacity and timeline considerations

- Geographic scope and market access

- Fee structure and commercial terms

1. Pre-submission Activities

- Pre-submission meetings and consultations

- Technical documentation readiness assessment

- Timeline and milestone planning

- Decision Point: Determine submission readiness and timing

Audit and Assessment Management

Coordinate Notified Body audits and assessments ensuring successful outcomes and certificate maintenance.

Audit Preparation Protocol:

• Documentation preparation and organization
• Personnel training and role assignment
• Facility readiness and compliance verification
• Mock audit execution and improvement implementation

MDR Guidance Monitoring

Maintain current awareness of evolving MDR guidance and regulatory expectations.

Guidance Tracking System:

• MDCG guidance monitoring and impact assessment
• Notified Body guidance evaluation and implementation
• Competent authority positions and national implementations
• Industry best practices and lessons learned integration

scripts/

• mdr-gap-analysis.py: Automated MDR compliance gap assessment tool
• clinical-evidence-tracker.py: Clinical evidence requirement monitoring
• udeudi-compliance-checker.py: UDI and EUDAMED compliance verification
• pms-reporting-automation.py: Post-market surveillance report generation

references/

• mdr-classification-guide.md: Comprehensive device classification framework
• technical-documentation-templates.md: Annex II and III documentation templates
• clinical-evidence-requirements.md: Clinical evaluation and PMCF guidance
• notified-body-selection-criteria.md: NB evaluation and selection framework
• mdcg-guidance-library.md: Current MDCG guidance compilation

assets/

• mdr-templates/: Technical file, clinical evaluation, and PMS plan templates
• gap-analysis-checklists/: MDR compliance assessment tools
• eudamed-forms/: EUDAMED registration and reporting templates
• training-materials/: MDR training presentations and compliance guides